Record Status This is a bibliographic record of a published health technology assessment. No evaluation of the quality of this assessment has been made for the HTA database. Citation Intra-articular injection of cross-linked hyaluronans for treatment of shoulder osteoarthritis. Lansdale: HAYES, Inc.. Healthcare Technology Brief Publication. 2014 Authors' conclusions Osteoarthritis (OA) is a degenerative disease of the joints that leads to pain and disability. OA of the shoulder is the result of deterioration of the articular surface of the humeral head and glenoid, specifically, degeneration of cartilage and narrowing of the glenohumeral joint space. There are medical and surgical treatment options for shoulder OA. First-line therapy is conservative, consisting of nonsteroidal anti-inflammatory drugs, physical therapy, corticosteroids, activity modification, and viscosupplementation. If symptoms are severe and disabling and unresponsive to medical therapy, the patient may require arthroscopy or partial or total shoulder joint replacement. Indexing Status Subject indexing assigned by CRD MeSH Hyaluronic Acids; Injections, Intra-Articular; Osteoarthritis Language Published English Country of organisation United States English summary An English language summary is available. Address for correspondence HAYES, Inc., 157 S. Broad Street, Suite 200, Lansdale, PA 19446, USA. Tel: 215 855 0615; Fax: 215 855 5218 Email: hayesinfo@hayesinc.com AccessionNumber 32014001211 Date abstract record published 29/10/2014 |